Mubadala and Novo Holdings are jointly investing €250 million in drug discovery and development firm Evotec
Mubadala and Novo Holdings are jointly investing €250 million in drug discovery and development firm Evotec

Economy

Mubadala and Novo Holdings invest €250m in drug discovery firm Evotec

Mubadala will invest €200m to subscribe to 5.6% of Evotec's outstanding shares, while Novo is investing €50m

Sarmad Khan
Sarmad Khan

October 13, 2020

On The Money

Make money work for you with news and expert analysis

      By signing up, I agree to The National's privacy policy
      On The Money